Efficacy and safety of donepezil 23. mg/d vs. donepezil 10 mg/d in patients with moderate to severe Alzheimer's disease.
Phase of Trial: Phase III
Latest Information Update: 16 Jun 2011
At a glance
- Drugs Donepezil (Primary)
- Indications Alzheimer's disease
- Focus Therapeutic Use
- Sponsors Eisai Inc
- 16 Jun 2011 New trial record
- 14 May 2011 Results presented at the Annual Scientific Meeting of the American Geriatrics Society (2011).